Guest, Erin M., John A. Kairalla, Meenakshi Devidas, Emily Hibbitts, Andrew J. Carroll, Nyla A. Heerema, Holly R. Kubaney, Margaret A. August, Sidharth Ramesh, Byunggil Yoo, Midhat S. Farooqi, Melinda G. Pauly, Daniel S. Wechsler, Rodney R. Miles, Joel M. Reid, Cynthia D. Kihei, Lia Gore, Elizabeth A. Raetz, Stephen P. Hunger, Mignon L. Loh, and Patrick A. Brown. 2020. “Azacitidine As Epigenetic Priming for Chemotherapy Is Safe and Well-Tolerated in Infants With Newly Diagnosed <i>KMT2A</I&gt;-Rearranged Acute Lymphoblastic Leukemia: Children’s Oncology Group Trial AALL15P1”. Haematologica, September. Pavia, Italy. https://doi.org/10.3324/haematol.2024.285158.